4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
New Ray Medicine International Holding Limited (6108) operates in the Pharmaceutical Retailers industry and is headquartered in Hangzhou, China with about 31 employees. Its market capitalization is roughly HK$45 million. In the fiscal year ended 2025-12-31, 6108 reported HK$130M in revenue and (HK$20M) in net income.
New Ray Medicine International Holding Limited, an investment holding company, engages in distribution and trading of pharmaceutical and related products in the People's Republic of China.
Interactive charts & full statements → Open the 6108 valuation workbench →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Revenue | HK$130M | HK$94M | HK$50M | HK$90M | — |
| Gross Profit | HK$16M | HK$12M | HK$13M | HK$13M | — |
| Operating Income (EBIT) | (HK$8M) | (HK$19M) | (HK$16M) | (HK$26M) | — |
| Net Income | (HK$20M) | (HK$31M) | (HK$22M) | (HK$78M) | — |
HKD; HK$M / HK$B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Assets | HK$436M | HK$505M | HK$492M | HK$540M | — |
| Total Liabilities | HK$12M | HK$34M | HK$11M | HK$14M | — |
HKD; HK$M / HK$B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive 6108 viewer.
About TickerBase · Data methodology & sources · Privacy · Terms